PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types
Translational Oncology · 2027-01 · 75 · 103127
DOI: 10.1016/j.tranon.2026.103127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2027-01. Verfasst von Wenyu Yang und 8 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Yang, W., Liu, A., Yue, J., Zhu, A., Bi, Z., Shi, S., Liu, J., Yang, J., & Yuan, P. (2027). PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types. Translational Oncology, 75, 103127. https://doi.org/10.1016/j.tranon.2026.103127
Vancouver
Yang W, Liu A, Yue J, Zhu A, Bi Z, Shi S, et al. PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types. Translational Oncology. 2027;75:103127. doi:10.1016/j.tranon.2026.103127
BibTeX
@article{Yang2027,
author = {Yang, Wenyu and Liu, Anqing and Yue, Jian and Zhu, Anjie and Bi, Zhao and Shi, Shufang and Liu, Jinyang and Yang, Jialiang and Yuan, Peng},
title = {PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types},
journal = {Translational Oncology},
year = {2027},
volume = {75},
pages = {103127},
doi = {10.1016/j.tranon.2026.103127}
}
EUVIMED